Dawn Ilardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dawn Ilardi has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
Adam R. Cassidy
Department of Psychiatry and Behavioral Sciences, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
3 shared publicationsJacqueline H. Sanz
Division of Neuropsychology, Children’s National Hospital, and Departments of Psychiatry and Behavioral Science and Pediatrics, George Washington University School of Medicine, Washington, DC, USA
3 shared publications- Alexander Tan
Department of Neuropsychology, Children’s Health Orange County, Orange, CA, USA
2 shared publications Anjali Sadhwani
Department of Psychiatry and Behavioral Sciences, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
2 shared publicationsBradley S. Marino
Department of Pediatric Cardiology, Cleveland Clinic Children’s, Cleveland, OH, USA
2 shared publications- Erica Sood
Thomas Jefferson University
2 shared publications
Latest Publications
- Open Access
- 20 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (2) , e042921
Neurocognitive and Psychological Interventions for Adults With Congenital Heart Disease: A Consensus Statement From the Adult Congenital Heart Disease/Neuro 2024 Conference
Adults with congenital heart disease (CHD) constitute a growing population with challenges related to cardiovascular and neurological health. Many individuals born with CHD experience neurodevelopmental delays in childhood. Ongoing neurocognitive and psychological concerns impact education, employment, and quality of life. Despite this, interventions to address these issues are largely unexplored. Collaborations among multidisciplinary experts and patient partners culminated at a 2‐day Adult Congenital Heart Disease (ACHD)/Neuro Conference (April 2024) to review the current state of knowledge and guide future directions for research and clinical care. Three working groups separately focused on genetics and brain health, characterizing outcomes, and interventions among patients with ACHD. This article focuses on the work of the interventions group. A consensus statement was created to synthesize current knowledge, identify key gaps, and recommend next steps around 5 critical questions designed to guide research and clinical care for interventions with ACHD: (1) What interventions are effective for improving neurocognitive functioning? (2) What interventions are effective for improving psychological wellbeing? (3) What evidence do we have about safety and efficacy of psychotropic medications? (4) What interventions can improve health literacy? (5) What are modifiable facilitators and barriers to accessing high‐quality neurocognitive and psychological interventions? Limited research and fragmented health systems hinder interventions in ACHD. Efforts from pediatric congenital heart disease could inform the ACHD community. Although interventions are costly and resource intensive, neglecting neurocognitive and psychological needs could lead to lower quality of life and higher health care costs. By ultimately shifting to prevention and intervention, the ACHD community could facilitate positive outcomes.
- 20 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (2) , e042921
Open AccessNeurocognitive and Psychological Interventions for Adults With Congenital Heart Disease: A Consensus Statement From the Adult Congenital Heart Disease/Neuro 2024 Conference
Adults with congenital heart disease (CHD) constitute a growing population with challenges related to cardiovascular and neurological health. Many individuals born with CHD experience neurodevelopmental delays in childhood. Ongoing neurocognitive and psychological concerns impact education, employment, and quality of life. Despite this, interventions to address these issues are largely unexplored. Collaborations among multidisciplinary experts and patient partners culminated at a 2‐day Adult Congenital Heart Disease (ACHD)/Neuro Conference (April 2024) to review the current state of knowledge and guide future directions for research and clinical care. Three working groups separately focused on genetics and brain health, characterizing outcomes, and interventions among patients with ACHD. This article focuses on the work of the interventions group. A consensus statement was created to synthesize current knowledge, identify key gaps, and recommend next steps around 5 critical questions designed to guide research and clinical care for interventions with ACHD: (1) What interventions are effective for improving neurocognitive functioning? (2) What interventions are effective for improving psychological wellbeing? (3) What evidence do we have about safety and efficacy of psychotropic medications? (4) What interventions can improve health literacy? (5) What are modifiable facilitators and barriers to accessing high‐quality neurocognitive and psychological interventions? Limited research and fragmented health systems hinder interventions in ACHD. Efforts from pediatric congenital heart disease could inform the ACHD community. Although interventions are costly and resource intensive, neglecting neurocognitive and psychological needs could lead to lower quality of life and higher health care costs. By ultimately shifting to prevention and intervention, the ACHD community could facilitate positive outcomes.
- 28 October 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (17) , 1246-1261
Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network’s Single Ventricle Reconstruction Trial
BACKGROUND: Neurodevelopmental and functional impairments are among the most consequential morbidities for survivors of hypoplastic left heart syndrome after staged single ventricle surgical palliation. The SVRIII trial (Long-Term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type) enrolled adolescents, who were randomized to different surgical shunt types at the time of Norwood procedure as neonates, for multifaceted in-person evaluation. This study reports their neurodevelopmental outcomes. METHODS: Transplant-free survivors from SVRIII were invited to complete an in-person comprehensive neurodevelopmental evaluation in early adolescence. Outcomes across domains of cognition, academics, learning, memory, and attention, as well as social, emotional, behavioral, adaptive, and executive function, were compared with those of normative populations. Associations with demographic and medical covariates, including Norwood shunt type, were also assessed. RESULTS: Among 549 participants enrolled in the SVR trial (Single Ventricle Reconstruction), 200 of the 237 SVRIII participants (84%) completed a neurodevelopmental evaluation at a mean age of 11 years (range, 10 to 14 years). SVRIII participants who did versus did not undergo evaluation were more likely to be male (63% versus 51%), to be White (87% versus 76%), and to have a higher Childhood Opportunity Index score (61±26 versus 46±39). Full-scale intelligence quotient (88±18) was significantly lower than in the normative population, with 39% >1 and 15% >2 SD below the normative mean. Similar patterns were seen for reading (38% >1 SD and 16% >2 SD below the normative mean) and math (38% >1 SD and 19% >2 SD below the normative mean) scores. Attention, executive functioning, social development, visual memory, and adaptive functioning were all more impaired than in the normative population. Measures of socioeconomic status, number of medical complications, and requirement for a gastrostomy tube were each independent predictors of neurodevelopment, with socioeconomic status the most consistently significant factor across models. Group differences by shunt type were inconsistent across neurodevelopmental domains without a clear benefit of one surgical strategy. CONCLUSIONS: In early adolescence, transplant-free survivors of surgical palliation for hypoplastic left heart syndrome show concerning impairments across all domains of neurodevelopment. The distribution of affected outcomes is broad and associated with demographic, medical, and, most frequently, socioeconomic factors. Our findings support recommendations for neurodevelopmental evaluation during adolescence to guide individualized interventions to promote educational success and psychosocial well-being. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02455531.
- 28 October 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (17) , 1246-1261
Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network’s Single Ventricle Reconstruction Trial
BACKGROUND: Neurodevelopmental and functional impairments are among the most consequential morbidities for survivors of hypoplastic left heart syndrome after staged single ventricle surgical palliation. The SVRIII trial (Long-Term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type) enrolled adolescents, who were randomized to different surgical shunt types at the time of Norwood procedure as neonates, for multifaceted in-person evaluation. This study reports their neurodevelopmental outcomes. METHODS: Transplant-free survivors from SVRIII were invited to complete an in-person comprehensive neurodevelopmental evaluation in early adolescence. Outcomes across domains of cognition, academics, learning, memory, and attention, as well as social, emotional, behavioral, adaptive, and executive function, were compared with those of normative populations. Associations with demographic and medical covariates, including Norwood shunt type, were also assessed. RESULTS: Among 549 participants enrolled in the SVR trial (Single Ventricle Reconstruction), 200 of the 237 SVRIII participants (84%) completed a neurodevelopmental evaluation at a mean age of 11 years (range, 10 to 14 years). SVRIII participants who did versus did not undergo evaluation were more likely to be male (63% versus 51%), to be White (87% versus 76%), and to have a higher Childhood Opportunity Index score (61±26 versus 46±39). Full-scale intelligence quotient (88±18) was significantly lower than in the normative population, with 39% >1 and 15% >2 SD below the normative mean. Similar patterns were seen for reading (38% >1 SD and 16% >2 SD below the normative mean) and math (38% >1 SD and 19% >2 SD below the normative mean) scores. Attention, executive functioning, social development, visual memory, and adaptive functioning were all more impaired than in the normative population. Measures of socioeconomic status, number of medical complications, and requirement for a gastrostomy tube were each independent predictors of neurodevelopment, with socioeconomic status the most consistently significant factor across models. Group differences by shunt type were inconsistent across neurodevelopmental domains without a clear benefit of one surgical strategy. CONCLUSIONS: In early adolescence, transplant-free survivors of surgical palliation for hypoplastic left heart syndrome show concerning impairments across all domains of neurodevelopment. The distribution of affected outcomes is broad and associated with demographic, medical, and, most frequently, socioeconomic factors. Our findings support recommendations for neurodevelopmental evaluation during adolescence to guide individualized interventions to promote educational success and psychosocial well-being. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02455531.
- 19 May 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 79-85
Development of the data registry for the Cardiac Neurodevelopmental Outcome Collaborative
Children with congenital heart disease (CHD) can face neurodevelopmental, psychological, and behavioural difficulties beginning in infancy and continuing through adulthood. Despite overall improvements in medical care and a growing focus on neurodevelopmental screening and evaluation in recent years, neurodevelopmental disabilities, delays, and deficits remain a concern. The Cardiac Neurodevelopmental Outcome Collaborative was founded in 2016 with the goal of improving neurodevelopmental outcomes for individuals with CHD and pediatric heart disease. This paper describes the establishment of a centralised clinical data registry to standardize data collection across member institutions of the Cardiac Neurodevelopmental Outcome Collaborative. The goal of this registry is to foster collaboration for large, multi-centre research and quality improvement initiatives that will benefit individuals and families with CHD and improve their quality of life. We describe the components of the registry, initial research projects proposed using data from the registry, and lessons learned in the development of the registry.
- 19 May 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (1) , 79-85
Development of the data registry for the Cardiac Neurodevelopmental Outcome Collaborative
Children with congenital heart disease (CHD) can face neurodevelopmental, psychological, and behavioural difficulties beginning in infancy and continuing through adulthood. Despite overall improvements in medical care and a growing focus on neurodevelopmental screening and evaluation in recent years, neurodevelopmental disabilities, delays, and deficits remain a concern. The Cardiac Neurodevelopmental Outcome Collaborative was founded in 2016 with the goal of improving neurodevelopmental outcomes for individuals with CHD and pediatric heart disease. This paper describes the establishment of a centralised clinical data registry to standardize data collection across member institutions of the Cardiac Neurodevelopmental Outcome Collaborative. The goal of this registry is to foster collaboration for large, multi-centre research and quality improvement initiatives that will benefit individuals and families with CHD and improve their quality of life. We describe the components of the registry, initial research projects proposed using data from the registry, and lessons learned in the development of the registry.
- Open Access
- 30 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (9) , 1604
Single Ventricle Reconstruction III: Brain Connectome and Neurodevelopmental Outcomes: Design, Recruitment, and Technical Challenges of a Multicenter, Observational Neuroimaging Study
Patients with hypoplastic left heart syndrome who have been palliated with the Fontan procedure are at risk for adverse neurodevelopmental outcomes, lower quality of life, and reduced employability. We describe the methods (including quality assurance and quality control protocols) and challenges of a multi-center observational ancillary study, SVRIII (Single Ventricle Reconstruction Trial) Brain Connectome. Our original goal was to obtain advanced neuroimaging (Diffusion Tensor Imaging and Resting-BOLD) in 140 SVR III participants and 100 healthy controls for brain connectome analyses. Linear regression and mediation statistical methods will be used to analyze associations of brain connectome measures with neurocognitive measures and clinical risk factors. Initial recruitment challenges occurred that were related to difficulties with: (1) coordinating brain MRI for participants already undergoing extensive testing in the parent study, and (2) recruiting healthy control subjects. The COVID-19 pandemic negatively affected enrollment late in the study. Enrollment challenges were addressed by: (1) adding additional study sites, (2) increasing the frequency of meetings with site coordinators, and (3) developing additional healthy control recruitment strategies, including using research registries and advertising the study to community-based groups. Technical challenges that emerged early in the study were related to the acquisition, harmonization, and transfer of neuroimages. These hurdles were successfully overcome with protocol modifications and frequent site visits that involved human and synthetic phantoms.
- 30 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (9) , 1604
Open AccessSingle Ventricle Reconstruction III: Brain Connectome and Neurodevelopmental Outcomes: Design, Recruitment, and Technical Challenges of a Multicenter, Observational Neuroimaging Study
Patients with hypoplastic left heart syndrome who have been palliated with the Fontan procedure are at risk for adverse neurodevelopmental outcomes, lower quality of life, and reduced employability. We describe the methods (including quality assurance and quality control protocols) and challenges of a multi-center observational ancillary study, SVRIII (Single Ventricle Reconstruction Trial) Brain Connectome. Our original goal was to obtain advanced neuroimaging (Diffusion Tensor Imaging and Resting-BOLD) in 140 SVR III participants and 100 healthy controls for brain connectome analyses. Linear regression and mediation statistical methods will be used to analyze associations of brain connectome measures with neurocognitive measures and clinical risk factors. Initial recruitment challenges occurred that were related to difficulties with: (1) coordinating brain MRI for participants already undergoing extensive testing in the parent study, and (2) recruiting healthy control subjects. The COVID-19 pandemic negatively affected enrollment late in the study. Enrollment challenges were addressed by: (1) adding additional study sites, (2) increasing the frequency of meetings with site coordinators, and (3) developing additional healthy control recruitment strategies, including using research registries and advertising the study to community-based groups. Technical challenges that emerged early in the study were related to the acquisition, harmonization, and transfer of neuroimages. These hurdles were successfully overcome with protocol modifications and frequent site visits that involved human and synthetic phantoms.
- 15 September 2022
- Published by Taylor & Francis in Child Neuropsychology
- Vol. 29 (7) , 1003-1020
Social-environmental factors as mediators of IQ and achievement differences across race groups in adolescents with high risk congenital heart disease
An increasing number of neuropsychologists are evaluating children with congenital heart disease (CHD). When conceptualizing results, the provider must consider medical risks such as abnormal neuroimaging and comorbidities, along with social risks such as socioeconomic status. The aim of the current study was to examine the influence of parent income and education on IQ and achievement across race groups in adolescents with CHD, while also accounting for medical risk (e.g., gestational age, number of ventricles, neuroimaging). This is a single-center cross-sectional study, including 92 children ages 12–19 years (median 14.9 years; 59% male; 71% White; 29% Black) with high risk CHD (i.e., cardiac surgery <12 months) who were referred for a neuropsychological evaluation. Retrospective data were retrieved from a larger clinical registry. Patients completed an intellectual assessment (WISC-V; WAIS-IV; WASI-II), Word Reading and Math Calculation tests. Parents completed questionnaires assessing the family environment [income, parent education]. Results revealed significant differences in IQ when comparing children who were Black versus White (11.4 point IQ difference); however, around 70% of this variance was explained by parent income and education. Medical variables accounted for 12% of the variance in IQ. For academics, parent income and education accounted for 91.5% and 78.8% of the variance in race group differences for reading and math, respectively. Medical risk and sex explained 11.7% and 14.7% of the variance in reading and math, respectively. Findings suggest that sociodemographic factors should be weighed heavily during the neuropsychological evaluation, including prioritizing risk, making recommendations, and facilitating referrals.
- 15 September 2022
- Published by Taylor & Francis in Child Neuropsychology
- Vol. 29 (7) , 1003-1020
Social-environmental factors as mediators of IQ and achievement differences across race groups in adolescents with high risk congenital heart disease
An increasing number of neuropsychologists are evaluating children with congenital heart disease (CHD). When conceptualizing results, the provider must consider medical risks such as abnormal neuroimaging and comorbidities, along with social risks such as socioeconomic status. The aim of the current study was to examine the influence of parent income and education on IQ and achievement across race groups in adolescents with CHD, while also accounting for medical risk (e.g., gestational age, number of ventricles, neuroimaging). This is a single-center cross-sectional study, including 92 children ages 12–19 years (median 14.9 years; 59% male; 71% White; 29% Black) with high risk CHD (i.e., cardiac surgery <12 months) who were referred for a neuropsychological evaluation. Retrospective data were retrieved from a larger clinical registry. Patients completed an intellectual assessment (WISC-V; WAIS-IV; WASI-II), Word Reading and Math Calculation tests. Parents completed questionnaires assessing the family environment [income, parent education]. Results revealed significant differences in IQ when comparing children who were Black versus White (11.4 point IQ difference); however, around 70% of this variance was explained by parent income and education. Medical variables accounted for 12% of the variance in IQ. For academics, parent income and education accounted for 91.5% and 78.8% of the variance in race group differences for reading and math, respectively. Medical risk and sex explained 11.7% and 14.7% of the variance in reading and math, respectively. Findings suggest that sociodemographic factors should be weighed heavily during the neuropsychological evaluation, including prioritizing risk, making recommendations, and facilitating referrals.
- 1 June 2022
- Published by American Psychological Association (APA) in Journal of Pediatric Neuropsychology
- Vol. 8 (2) , 68-78
Adaptive functioning in adolescents with congenital heart disease referred for neurodevelopmental follow-up.
Objective Limited outcome research so far suggests concerns about adaptive functioning in children with congenital heart disease (CHD). Given the importance of adaptive skills for functional independence, supporting progress in the high-risk CHD population could allow for timely identification and intervention as needed. The goal of the current study is to characterize adaptive functioning abilities in a high-risk clinical sample of adolescents with CHD. Methods Participants (n = 109) included adolescents (ages 12–20; mean = 14 years) with high-risk CHD (i.e., cardiac surgery < 12 months) who were clinically referred for a cardiac neurodevelopmental evaluation between 2015 and 2020. Retrospective data was retrieved from a larger clinical registry in the Cardiac Neurodevelopmental Program and included standardized measures of adaptive, intellectual, and academic abilities. Descriptive, strengths and weaknesses, and correlational analyses were completed. Results Functional independence in this sample was below age expectations across six of the nine adaptive skill areas. Demographic and medical risk factors were not associated with adaptive outcomes. Lower adaptive skills were associated with two-ventricle CHD, higher service utilization, lower intellectual and academic abilities, and developmental diagnoses. The sample exhibited relative strengths in communication, leisure, and health and safety, and relative weaknesses in functional academics, self-direction, social, and home living skills. Conclusions Findings support that adolescents with high-risk CHD typically followed by cardiac neurodevelopmental programs show delayed functional skills integral in the transition to adulthood. Avenues for supporting development of adaptive functioning skills are discussed.
- 1 June 2022
- Published by American Psychological Association (APA) in Journal of Pediatric Neuropsychology
- Vol. 8 (2) , 68-78
Adaptive functioning in adolescents with congenital heart disease referred for neurodevelopmental follow-up.
Objective Limited outcome research so far suggests concerns about adaptive functioning in children with congenital heart disease (CHD). Given the importance of adaptive skills for functional independence, supporting progress in the high-risk CHD population could allow for timely identification and intervention as needed. The goal of the current study is to characterize adaptive functioning abilities in a high-risk clinical sample of adolescents with CHD. Methods Participants (n = 109) included adolescents (ages 12–20; mean = 14 years) with high-risk CHD (i.e., cardiac surgery < 12 months) who were clinically referred for a cardiac neurodevelopmental evaluation between 2015 and 2020. Retrospective data was retrieved from a larger clinical registry in the Cardiac Neurodevelopmental Program and included standardized measures of adaptive, intellectual, and academic abilities. Descriptive, strengths and weaknesses, and correlational analyses were completed. Results Functional independence in this sample was below age expectations across six of the nine adaptive skill areas. Demographic and medical risk factors were not associated with adaptive outcomes. Lower adaptive skills were associated with two-ventricle CHD, higher service utilization, lower intellectual and academic abilities, and developmental diagnoses. The sample exhibited relative strengths in communication, leisure, and health and safety, and relative weaknesses in functional academics, self-direction, social, and home living skills. Conclusions Findings support that adolescents with high-risk CHD typically followed by cardiac neurodevelopmental programs show delayed functional skills integral in the transition to adulthood. Avenues for supporting development of adaptive functioning skills are discussed.
- Open Access
- 24 February 2022
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (2) , 280-287
Telehealth services for cardiac neurodevelopmental care during the COVID-19 pandemic: a site survey from the Cardiac Neurodevelopmental Outcome Collaborative
Objective: COVID-19 has markedly impacted the provision of neurodevelopmental care. In response, the Cardiac Neurodevelopmental Outcome Collaborative established a Task Force to assess the telehealth practices of cardiac neurodevelopmental programmes during COVID-19, including adaptation of services, test protocols and interventions, and perceived obstacles, disparities, successes, and training needs.Study Design: A 47-item online survey was sent to 42 Cardiac Neurodevelopmental Outcome Collaborative member sites across North America within a 3-week timeframe (22 July to 11 August 2020) to collect cross-sectional data on practices.Results: Of the 30 participating sites (71.4% response rate), all were providing at least some clinical services at the time of the survey and 24 sites (80%) reported using telehealth. All but one of these sites were offering new telehealth services in response to COVID-19, with the most striking change being the capacity to offer new intervention services for children and their caregivers. Only a third of sites were able to carry out standardised, performance-based, neurodevelopmental testing with children and adolescents using telehealth, and none had completed comparable testing with infants and toddlers. Barriers associated with language, child ability, and access to technology were identified as contributing to disparities in telehealth access.Conclusions: Telehealth has enabled continuation of at least some cardiac neurodevelopmental services during COVID-19, despite the challenges experienced by providers, children, families, and health systems. The Cardiac Neurodevelopmental Outcome Collaborative provides a unique platform for sharing challenges and successes across sites, as we continue to shape an evidence-based, efficient, and consistent approach to the care of individuals with CHD.
- 24 February 2022
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (2) , 280-287
Open AccessTelehealth services for cardiac neurodevelopmental care during the COVID-19 pandemic: a site survey from the Cardiac Neurodevelopmental Outcome Collaborative
Objective: COVID-19 has markedly impacted the provision of neurodevelopmental care. In response, the Cardiac Neurodevelopmental Outcome Collaborative established a Task Force to assess the telehealth practices of cardiac neurodevelopmental programmes during COVID-19, including adaptation of services, test protocols and interventions, and perceived obstacles, disparities, successes, and training needs.Study Design: A 47-item online survey was sent to 42 Cardiac Neurodevelopmental Outcome Collaborative member sites across North America within a 3-week timeframe (22 July to 11 August 2020) to collect cross-sectional data on practices.Results: Of the 30 participating sites (71.4% response rate), all were providing at least some clinical services at the time of the survey and 24 sites (80%) reported using telehealth. All but one of these sites were offering new telehealth services in response to COVID-19, with the most striking change being the capacity to offer new intervention services for children and their caregivers. Only a third of sites were able to carry out standardised, performance-based, neurodevelopmental testing with children and adolescents using telehealth, and none had completed comparable testing with infants and toddlers. Barriers associated with language, child ability, and access to technology were identified as contributing to disparities in telehealth access.Conclusions: Telehealth has enabled continuation of at least some cardiac neurodevelopmental services during COVID-19, despite the challenges experienced by providers, children, families, and health systems. The Cardiac Neurodevelopmental Outcome Collaborative provides a unique platform for sharing challenges and successes across sites, as we continue to shape an evidence-based, efficient, and consistent approach to the care of individuals with CHD.
- 4 June 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (6) , 876-887
Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative
The Neurodevelopmental and Psychological Outcomes Working Group of the Cardiac Neurodevelopmental Outcome Collaborative was formed in 2018 through support from an R13 grant from the National Heart, Lung, and Blood Institute with the goals of identifying knowledge gaps regarding the neurodevelopmental and psychological outcomes of individuals with CHD and investigations needed to advance science, policy, clinical care, and patient/family outcomes. Accurate characterisation of neurodevelopmental and psychological outcomes in children with CHD will drive improvements in patient and family outcomes through targeted intervention. Decades of research have produced a generalised perspective about neurodevelopmental and psychological outcomes in this heterogeneous population. Future investigations need to shift towards improving methods, measurement, and analyses of outcomes to better inform early identification, prevention, and intervention. Improved definition of underlying developmental, neuropsychological, and social-emotional constructs is needed, with an emphasis on symptom networks and dimensions. Identification of clinically meaningful outcomes that are most important to key stakeholders, including patients, families, schools and providers, is essential, specifically how and which neurodevelopmental differences across the developmental trajectory impact stakeholders. A better understanding of the discontinuity and patterns of neurodevelopment across the lifespan is critical as well, with some areas being more impactful at some ages than others. Finally, the field needs to account for the impact of race/ethnicity, socio-economic status, cultural and linguistic diversity on our measurement, interpretation of data, and approach to intervention and how to improve generalisability to the larger worldwide population of patients and families living with CHD.
- 4 June 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (6) , 876-887
Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative
The Neurodevelopmental and Psychological Outcomes Working Group of the Cardiac Neurodevelopmental Outcome Collaborative was formed in 2018 through support from an R13 grant from the National Heart, Lung, and Blood Institute with the goals of identifying knowledge gaps regarding the neurodevelopmental and psychological outcomes of individuals with CHD and investigations needed to advance science, policy, clinical care, and patient/family outcomes. Accurate characterisation of neurodevelopmental and psychological outcomes in children with CHD will drive improvements in patient and family outcomes through targeted intervention. Decades of research have produced a generalised perspective about neurodevelopmental and psychological outcomes in this heterogeneous population. Future investigations need to shift towards improving methods, measurement, and analyses of outcomes to better inform early identification, prevention, and intervention. Improved definition of underlying developmental, neuropsychological, and social-emotional constructs is needed, with an emphasis on symptom networks and dimensions. Identification of clinically meaningful outcomes that are most important to key stakeholders, including patients, families, schools and providers, is essential, specifically how and which neurodevelopmental differences across the developmental trajectory impact stakeholders. A better understanding of the discontinuity and patterns of neurodevelopment across the lifespan is critical as well, with some areas being more impactful at some ages than others. Finally, the field needs to account for the impact of race/ethnicity, socio-economic status, cultural and linguistic diversity on our measurement, interpretation of data, and approach to intervention and how to improve generalisability to the larger worldwide population of patients and families living with CHD.
- 1 March 2021
- Published by SAGE Publications in Clinical Practice in Pediatric Psychology
- Vol. 9 (1) , 35-45
Cognitive Mechanisms That Predict Lower Math in Children With Congenital Heart Disease
Objective: Broad cognitive deficits have been reported in children with congenital heart disease (CHD), which is associated with abnormal neurological development. As cardiac neurodevelopmental follow-up programs grow to meet patient demands, research is needed to guide clinical care. Of interest to the current study are deficits in fine motor and visuospatial skills, processing speed, and working memory in CHD, which are known contributors to math. Method: Retrospective chart review was completed from an outpatient clinic to collect data from neuropsychology and medical records. Evaluations were completed upon physician referral and represent a high-risk clinical sample. Participants included 105 children ( M age = 10 years) with various types of CHD requiring surgery during infancy. Measures included standardized testing and caregiver ratings. Results: Using hierarchical linear regression, perceptual reasoning, processing speed, and working memory explained significant variance in math. Demographic variables (e.g., maternal education, ethnicity), prematurity, and CHD severity were not related to math. Caregiver report of executive function was also unrelated to math. Conclusions: Psychologists completing an evaluation of the clinically referred child with CHD should assess visuospatial skills, working memory, and processing speed when math is a concern. Identifying weaknesses in these areas can inform math instruction and accommodations. Implications for Impact Statement: This study of clinically referred children with CHD shows lower performance in math. Cognitive areas related to lower math included visuospatial skills, working memory, and processing speed. Findings support assessment of these areas in cardiac neurodevelopmental follow-up programs to help facilitate intervention.
- 1 March 2021
- Published by SAGE Publications in Clinical Practice in Pediatric Psychology
- Vol. 9 (1) , 35-45
Cognitive Mechanisms That Predict Lower Math in Children With Congenital Heart Disease
Objective: Broad cognitive deficits have been reported in children with congenital heart disease (CHD), which is associated with abnormal neurological development. As cardiac neurodevelopmental follow-up programs grow to meet patient demands, research is needed to guide clinical care. Of interest to the current study are deficits in fine motor and visuospatial skills, processing speed, and working memory in CHD, which are known contributors to math. Method: Retrospective chart review was completed from an outpatient clinic to collect data from neuropsychology and medical records. Evaluations were completed upon physician referral and represent a high-risk clinical sample. Participants included 105 children ( M age = 10 years) with various types of CHD requiring surgery during infancy. Measures included standardized testing and caregiver ratings. Results: Using hierarchical linear regression, perceptual reasoning, processing speed, and working memory explained significant variance in math. Demographic variables (e.g., maternal education, ethnicity), prematurity, and CHD severity were not related to math. Caregiver report of executive function was also unrelated to math. Conclusions: Psychologists completing an evaluation of the clinically referred child with CHD should assess visuospatial skills, working memory, and processing speed when math is a concern. Identifying weaknesses in these areas can inform math instruction and accommodations. Implications for Impact Statement: This study of clinically referred children with CHD shows lower performance in math. Cognitive areas related to lower math included visuospatial skills, working memory, and processing speed. Findings support assessment of these areas in cardiac neurodevelopmental follow-up programs to help facilitate intervention.
- Open Access
- 1 January 2021
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 63 (1) , 8-9
Meta-analysis in congenital heart disease: a question of sampling and interpretation
- 1 January 2021
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 63 (1) , 8-9
Open AccessMeta-analysis in congenital heart disease: a question of sampling and interpretation